NECTIN2
Basic information
Region (hg38): 19:44846175-44889223
Previous symbols: [ "HVEB", "PVRL2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NECTIN2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 14 | 17 | ||||
missense | 13 | |||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 2 | |||||
Total | 0 | 0 | 6 | 22 | 8 |
Variants in NECTIN2
This is a list of pathogenic ClinVar variants found in the NECTIN2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-44865261-C-T | NECTIN2-related disorder | Likely benign (May 06, 2022) | ||
19-44865306-G-A | not specified | Uncertain significance (Nov 15, 2021) | ||
19-44865309-C-T | Cerebral palsy | Uncertain significance (Jun 10, 2021) | ||
19-44865321-G-A | not specified | Uncertain significance (Oct 18, 2021) | ||
19-44865329-C-T | NECTIN2-related disorder | Likely benign (Aug 10, 2019) | ||
19-44865341-G-A | NECTIN2-related disorder | Likely benign (May 02, 2019) | ||
19-44865470-G-A | NECTIN2-related disorder | Likely benign (Sep 17, 2019) | ||
19-44865545-G-A | NECTIN2-related disorder | Likely benign (Sep 19, 2019) | ||
19-44865548-C-T | Benign (May 31, 2018) | |||
19-44865554-G-A | NECTIN2-related disorder | Likely benign (Jun 05, 2019) | ||
19-44871836-TCTC-T | NECTIN2-related disorder | Likely benign (Apr 29, 2024) | ||
19-44871890-G-A | NECTIN2-related disorder | Benign (Oct 28, 2019) | ||
19-44871900-G-C | NECTIN2-related disorder | Benign (Jun 01, 2018) | ||
19-44871907-C-T | NECTIN2-related disorder | Likely benign (Mar 10, 2023) | ||
19-44872016-C-T | NECTIN2-related disorder | Likely benign (May 02, 2019) | ||
19-44872038-C-T | NECTIN2-related disorder | Likely benign (May 06, 2022) | ||
19-44873962-C-T | NECTIN2-related disorder | Likely benign (Jan 01, 2023) | ||
19-44873997-G-A | Benign (May 30, 2018) | |||
19-44874348-G-A | NECTIN2-related disorder | Likely benign (May 16, 2024) | ||
19-44874354-C-T | NECTIN2-related disorder | Likely benign (Aug 14, 2019) | ||
19-44878273-G-A | Benign (Mar 01, 2023) | |||
19-44878275-G-T | NECTIN2-related disorder | Likely benign (Nov 01, 2019) | ||
19-44878340-T-TGAG | NECTIN2-related disorder | Likely benign (Mar 26, 2023) | ||
19-44878350-G-A | NECTIN2-related disorder | Likely benign (May 28, 2019) | ||
19-44878362-T-TGGAGGAGCAGGA | NECTIN2-related disorder | Likely benign (Sep 01, 2020) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NECTIN2 | protein_coding | protein_coding | ENST00000252483 | 9 | 43054 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.969 | 0.0307 | 124796 | 0 | 4 | 124800 | 0.0000160 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.64 | 241 | 324 | 0.743 | 0.0000199 | 3398 |
Missense in Polyphen | 54 | 100.88 | 0.53531 | 1019 | ||
Synonymous | 0.596 | 134 | 143 | 0.937 | 0.00000938 | 1182 |
Loss of Function | 3.97 | 3 | 24.0 | 0.125 | 0.00000144 | 242 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000646 | 0.0000645 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000556 | 0.0000556 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000177 | 0.0000177 |
Middle Eastern | 0.0000556 | 0.0000556 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Modulator of T-cell signaling. Can be either a costimulator of T-cell function, or a coinhibitor, depending on the receptor it binds to. Upon binding to CD226, stimulates T-cell proliferation and cytokine production, including that of IL2, IL5, IL10, IL13, and IFNG. Upon interaction with PVRIG, inhibits T-cell proliferation. These interactions are competitive (PubMed:26755705). Probable cell adhesion protein (PubMed:9657005). {ECO:0000269|PubMed:26755705, ECO:0000269|PubMed:9657005}.;
- Pathway
- Cell adhesion molecules (CAMs) - Homo sapiens (human);Adherens junction - Homo sapiens (human);Herpes simplex infection - Homo sapiens (human);Monoamine Transport;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Adaptive Immune System;Cell-cell junction organization;Nectin/Necl trans heterodimerization;Adherens junctions interactions;Cell junction organization;Cell-Cell communication;Stabilization and expansion of the E-cadherin adherens junction;Nectin adhesion pathway
(Consensus)
Recessive Scores
- pRec
- 0.175
Intolerance Scores
- loftool
- rvis_EVS
- 0.56
- rvis_percentile_EVS
- 81.63
Haploinsufficiency Scores
- pHI
- 0.114
- hipred
- Y
- hipred_score
- 0.538
- ghis
- 0.409
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Nectin2
- Phenotype
- reproductive system phenotype; cellular phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- acrosome assembly;positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target;positive regulation of immunoglobulin mediated immune response;cytoskeleton organization;homophilic cell adhesion via plasma membrane adhesion molecules;spermatid development;spermatid nucleus differentiation;fertilization;fusion of virus membrane with host plasma membrane;sperm mitochondrion organization;cell part morphogenesis;positive regulation of mast cell activation;adherens junction organization;susceptibility to natural killer cell mediated cytotoxicity;adhesion of symbiont to host;cilium organization;positive regulation of natural killer cell mediated cytotoxicity;regulation of viral entry into host cell;coreceptor-mediated virion attachment to host cell;regulation of immune response;positive regulation of T cell receptor signaling pathway;establishment of mitochondrion localization;susceptibility to T cell mediated cytotoxicity
- Cellular component
- plasma membrane;cell-cell junction;zonula adherens;focal adhesion;cell surface;integral component of membrane;cell-cell contact zone;extracellular exosome
- Molecular function
- virus receptor activity;protein binding;coreceptor activity;identical protein binding;protein homodimerization activity;cell adhesion molecule binding